Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Immunity ; 54(9): 2024-2041.e8, 2021 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-34473957

RESUMEN

Sepsis results in elevated adenosine in circulation. Extracellular adenosine triggers immunosuppressive signaling via the A2a receptor (A2aR). Sepsis survivors develop persistent immunosuppression with increased risk of recurrent infections. We utilized the cecal ligation and puncture (CLP) model of sepsis and subsequent infection to assess the role of adenosine in post-sepsis immune suppression. A2aR-deficient mice showed improved resistance to post-sepsis infections. Sepsis expanded a subset of CD39hi B cells and elevated extracellular adenosine, which was absent in mice lacking CD39-expressing B cells. Sepsis-surviving B cell-deficient mice were more resistant to secondary infections. Mechanistically, metabolic reprogramming of septic B cells increased production of ATP, which was converted into adenosine by CD39 on plasmablasts. Adenosine signaling via A2aR impaired macrophage bactericidal activity and enhanced interleukin-10 production. Septic individuals exhibited expanded CD39hi plasmablasts and adenosine accumulation. Our study reveals CD39hi plasmablasts and adenosine as important drivers of sepsis-induced immunosuppression with relevance in human disease.


Asunto(s)
Adenosina/inmunología , Antígenos CD/inmunología , Apirasa/inmunología , Tolerancia Inmunológica/inmunología , Macrófagos/inmunología , Células Plasmáticas/inmunología , Sepsis/inmunología , Adenosina/metabolismo , Animales , Antígenos CD/metabolismo , Apirasa/metabolismo , Reprogramación Celular/inmunología , Macrófagos/metabolismo , Ratones , Células Plasmáticas/metabolismo , Receptor de Adenosina A2A/inmunología , Receptor de Adenosina A2A/metabolismo , Sepsis/metabolismo
2.
J Infect Dis ; 215(3): 387-395, 2017 02 01.
Artículo en Inglés | MEDLINE | ID: mdl-28003350

RESUMEN

Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects 7 million people in Latin American areas of endemicity. About 30% of infected patients will develop chronic Chagas cardiomyopathy (CCC), an inflammatory cardiomyopathy characterized by hypertrophy, fibrosis, and myocarditis. Further studies are necessary to understand the molecular mechanisms of disease progression. Transcriptome analysis has been increasingly used to identify molecular changes associated with disease outcomes. We thus assessed the whole-blood transcriptome of patients with Chagas disease. Microarray analysis was performed on blood samples from 150 subjects, of whom 30 were uninfected control patients and 120 had Chagas disease (1 group had asymptomatic disease, and 2 groups had CCC with either a preserved or reduced left ventricular ejection fraction [LVEF]). Each Chagas disease group displayed distinct gene expression and functional pathway profiles. The most different expression patterns were between CCC groups with a preserved or reduced LVEF. A more stringent analysis indicated that 27 differentially expressed genes, particularly those related to natural killer (NK)/CD8+ T-cell cytotoxicity, separated the 2 groups. NK/CD8+ T-cell cytotoxicity could play a role in determining Chagas disease progression. Understanding genes associated with disease may lead to improved insight into CCC pathogenesis and the identification of prognostic factors for CCC progression.


Asunto(s)
Cardiomiopatía Chagásica/genética , Disfunción Ventricular/genética , Linfocitos T CD8-positivos/inmunología , Cardiomiopatía Chagásica/sangre , Cardiomiopatía Chagásica/fisiopatología , Citotoxicidad Inmunológica/genética , Perfilación de la Expresión Génica , Redes Reguladoras de Genes , Humanos , Células Asesinas Naturales/inmunología , Análisis por Micromatrices , Persona de Mediana Edad , Miocardio/patología , Reacción en Cadena en Tiempo Real de la Polimerasa , Disfunción Ventricular/sangre , Disfunción Ventricular/parasitología
3.
Cell Immunol ; 300: 18-25, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26632272

RESUMEN

Myeloperoxidase (MPO) is an important enzyme in the front-line protection against microorganisms. In peripheral blood, it is accepted that MPO is only produced by myeloid-lineage cells. Thus, MPO presence is unexpected in lymphocytes. We showed recently that B1-lymphocytes from mice have MPO. Here, we showed that subsets of human peripheral B, CD4(+) and CD8(+) T lymphocytes express MPO. The content of MPO in lymphocytes was very low compared to neutrophils/monocytes with a preferential distribution in the nucleus and perinuclear region. Also, we performed a MPO mRNA expression analysis from human blood cells derived from microarray raw data publicly available, showing that MPO is modulated in infectious disease. MPO was increased in CD4(+) T lymphocytes from HIV chronic infection and in CD8(+) T lymphocytes from HCV-positive patients. Our study points out MPO as a multifunctional protein due to its subcellular localization and expression modulation in lymphocytes indicating alternative unknown functions for MPO in lymphocytes.


Asunto(s)
Linfocitos B/enzimología , Linfocitos T CD4-Positivos/enzimología , Linfocitos T CD8-positivos/enzimología , Peroxidasa/biosíntesis , Linfocitos B/inmunología , Western Blotting , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Separación Celular , Citometría de Flujo , Infecciones por VIH/enzimología , Infecciones por VIH/inmunología , Hepatitis C/enzimología , Hepatitis C/inmunología , Humanos , Inmunofenotipificación , Microscopía Electrónica de Transmisión , Microscopía Fluorescente , Análisis de Secuencia por Matrices de Oligonucleótidos , Peroxidasa/inmunología , Reacción en Cadena en Tiempo Real de la Polimerasa
5.
Front Immunol ; 12: 624191, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33777004

RESUMEN

In spite of several decades of research, an effective vaccine against schistosomiasis remains elusive. The radiation-attenuated (RA) cercarial vaccine is still the best model eliciting high protection levels, although the immune mechanisms have not yet been fully characterized. In order to identify genes and pathways underlying protection we investigated patterns of gene expression in PBMC and skin draining Lymph Nodes (LN) from mice using two exposure comparisons: vaccination with 500 attenuated cercariae versus infection with 500 normal cercariae; one versus three doses. Vaccinated mice were challenged with 120 normal parasites. Integration of PBMC and LN data from the infected group revealed early up-regulation of pathways associated with Th2 skewing and polarization of IgG antibody profiles. Additionally, hemostasis pathways were downregulated in infected mice, correlating with platelet reduction, potentially a mechanism to assist parasite migration through capillary beds. Conversely, up regulation of such mechanisms after vaccination may explain parasite blockade in the lungs. In contrast, a single exposure to attenuated parasites revealed early establishment of a Th1 bias (signaling of IL-1, IFN-γ; and Leishmania infection). Genes encoding chemokines and their receptors were more prominent in vaccinated mice, indicating an enhanced capacity for inflammation, potentially augmenting the inhibition of intravascular migration. Increasing the vaccinations from one to three did not dramatically elevate protection, but there was a clear shift towards antibody-mediated effectors. However, elements of the Th1 bias were still evident. Notable features after three vaccinations were markers of cytotoxicity (including IL-6 and NK cells) together with growth factors and their receptors (FGFR/VEGF/EGF) and the apoptosis pathway. Indeed, there is evidence for the development of anergy after three vaccinations, borne out by the limited responses detected in samples after challenge. We infer that persistence of a Th1 response puts a limit on expression of antibody-mediated mechanisms. This feature may explain the failure of multiple doses to drive protection towards sterile immunity. We suggest that the secretions of lung stage parasites would make a novel cohort of antigens for testing in protection experiments.


Asunto(s)
Hemostasis , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Vacunas Antiprotozoos/administración & dosificación , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/prevención & control , Biología de Sistemas , Animales , Cercarias/inmunología , Modelos Animales de Enfermedad , Femenino , Perfilación de la Expresión Génica , Hemostasis/genética , Interacciones Huésped-Parásitos , Péptidos y Proteínas de Señalización Intercelular/genética , Ganglios Linfáticos/inmunología , Ganglios Linfáticos/metabolismo , Ganglios Linfáticos/parasitología , Ratones Endogámicos C57BL , Análisis por Micromatrices , Vacunas Antiprotozoos/inmunología , Schistosoma mansoni/patogenicidad , Esquistosomiasis mansoni/inmunología , Esquistosomiasis mansoni/metabolismo , Esquistosomiasis mansoni/parasitología , Células TH1/inmunología , Células TH1/metabolismo , Células TH1/parasitología , Balance Th1 - Th2 , Células Th2/inmunología , Células Th2/metabolismo , Células Th2/parasitología , Factores de Tiempo , Transcriptoma , Vacunación , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/inmunología
6.
Front Cell Infect Microbiol ; 11: 672472, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34026666

RESUMEN

The risk of developing severe forms of tuberculosis has increased by the acquired immunodeficiency syndrome (AIDS) epidemic, lack of effective drugs to eliminate latent infection and the emergence of drug-resistant mycobacterial strains. Excessive inflammatory response and tissue damage associated with severe tuberculosis contribute to poor outcome of the disease. Our previous studies using mice deficient in the ATP-gated ionotropic P2X7 receptor suggested this molecule as a promising target for host-directed therapy in severe pulmonary tuberculosis. In this study, we assessed the effects of P2X7 pharmacological blockade on disease severity. First, we observed an increase in P2RX7 gene expression in the peripheral blood of tuberculosis patients compared to healthy donors. Lung leukocytes of mice infected with hypervirulent mycobacteria also showed increased expression of the P2X7 receptor. P2X7 blockade in mice with advanced tuberculosis recapitulated in many aspects the disease in P2X7-deficient mice. P2X7-directed therapy reduced body weight loss and the development of inflammatory and necrotic lung lesions, as well as delayed mycobacterial growth. Lower TNF-α production by lung cells and a substantial reduction in the lung GR-1+ myeloid cell population were observed after P2X7 inhibition. The effector CD4+ T cell population also decreased, but IFN-γ production by lung cells increased. The presence of a large population with characteristics of myeloid dendritic cells, as well as the increase in IL-6 production by lung cells, also indicate a qualitative improvement in the pulmonary immune response due to P2X7 inhibition. These findings support the use of drugs that target the P2X7 receptor as a therapeutic strategy to improve the outcome of pulmonary tuberculosis.


Asunto(s)
Neumonía , Tuberculosis Pulmonar , Tuberculosis , Animales , Humanos , Pulmón , Ratones , Ratones Endogámicos C57BL , Necrosis , Receptores Purinérgicos P2X7
7.
Transl Psychiatry ; 10(1): 141, 2020 05 12.
Artículo en Inglés | MEDLINE | ID: mdl-32398742

RESUMEN

Psychiatric and neurological disorders (PNDs) affect millions worldwide and only a few drugs achieve complete therapeutic success in the treatment of these disorders. Due to the high cost of developing novel drugs, drug repositioning represents a promising alternative method of treatment. In this manuscript, we used a network medicine approach to investigate the molecular characteristics of PNDs and identify novel drug candidates for repositioning. Using IBM Watson for Drug Discovery, a powerful machine learning text-mining application, we built knowledge networks containing connections between PNDs and genes or drugs mentioned in the scientific literature published in the past 50 years. This approach revealed several drugs that target key PND-related genes, which have never been used to treat these disorders to date. We validate our framework by detecting drugs that have been undergoing clinical trial for treating some of the PNDs, but have no published results in their support. Our data provides comprehensive insights into the molecular pathology of PNDs and offers promising drug repositioning candidates for follow-up trials.


Asunto(s)
Reposicionamiento de Medicamentos , Enfermedades del Sistema Nervioso , Biología Computacional , Minería de Datos , Humanos , Aprendizaje Automático , Enfermedades del Sistema Nervioso/tratamiento farmacológico
8.
Phys Rev E ; 97(4-1): 042417, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29758668

RESUMEN

The biological processes of cellular decision making and differentiation involve a plethora of signaling pathways and gene regulatory circuits. These networks in turn exhibit a multitude of motifs playing crucial parts in regulating network activity. Here we compare the topological placement of motifs in gene regulatory and signaling networks and observe that it suggests different evolutionary strategies in motif distribution for distinct cellular subnetworks.


Asunto(s)
Redes Reguladoras de Genes , Modelos Biológicos , Transducción de Señal , Animales , Humanos , Ratones
9.
Oncotarget ; 8(6): 9597-9607, 2017 Feb 07.
Artículo en Inglés | MEDLINE | ID: mdl-28030816

RESUMEN

Papillary thyroid carcinoma (PTC) is the most prevalent malignant neoplasia of the thyroid gland. A fraction of PTC cases show loss of differentiation and aggressive behavior, with radioiodine therapy resistance and metastasis. Although microRNAs (miRNAs) emerged as promising molecular markers for PTC, their role in the loss of differentiation observed during PTC progression remains to be fully understood. We performed the large-scale analysis of miRNA expression during PTC progression in BRAFT1799A-transgenic animals (Tg-Braf) and thyroid cancer cell lines and identified the marked downregulation of several miRNAs from the region 14q32. Data from The Cancer Genome Atlas (TCGA) confirmed the global downregulation of miRNAs from the 14q32 region in human PTC. The regulatory network potentially suppressed by these miRNAs suggests that key cancer-related biological processes such as cell proliferation, adhesion, migration and angiogenesis. Among the downregulated miRNAs, we observed that miR-654-3p levels decrease with long-term PTC progression in Tg-Braf mice and inversely correlate with EMT. The in vitro restoration of miR-654-3p decreased cell proliferation and migration and induced reprogramming of metastasis-related genes, suggesting a tumor suppressor role for this miRNA. In conclusion, we show global downregulation of 14q32-encoded miRNAs in an in vivo model of PTC progression. The potential circuitry in which these miRNAs are involved suggests that these miRNAs could play a key role in the pathophysiology of PTC and therefore be relevant for the development of new therapeutic strategies.


Asunto(s)
Carcinoma Papilar/genética , Cromosomas Humanos Par 14 , Regulación Neoplásica de la Expresión Génica , MicroARNs/genética , Neoplasias de la Tiroides/genética , Animales , Carcinoma Papilar/metabolismo , Línea Celular Tumoral , Progresión de la Enfermedad , Regulación hacia Abajo , Transición Epitelial-Mesenquimal , Redes Reguladoras de Genes , Predisposición Genética a la Enfermedad , Humanos , Ratones Transgénicos , MicroARNs/metabolismo , Mutación , Fenotipo , Proteínas Proto-Oncogénicas B-raf/genética , Procesamiento Postranscripcional del ARN , Transducción de Señal , Cáncer Papilar Tiroideo , Neoplasias de la Tiroides/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA